Physician

Sakina A Kamal, M.D.

According to 2025 Medicare claims, Sakina Kamal, M.D. (NPI: 1619961000) practices cardiology in the Tuscaloosa, AL market, with the plurality of this provider's patient population coming from Tuscaloosa, AL. This provider's primary affiliated billing organization is CARDIOLOGY ASSOCIATES OF WEST ALABAMA, PC (NPI: 1669573721; TIN: 63-1059761) and primary practice location at 35473-5197.

Kamal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 789 traditional Medicare patients, billed 8,309 HCPCS/CPT codes, and received $413,714 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,889 prescription claims across 1,239 beneficiaries totaling $2,002,191 in drug costs, led by Eliquis (Apixaban). DME data shows 22 claims. Open Payments data shows 28 records totaling $608. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $644,356 to $413,714. In contrast, Part D prescription costs have moved sharply higher in recent years, from $283,404 to $2,002,191. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $26,845 to $50,510.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,044	11,259	$644,356
2016	3,194	16,137	$1,030,532
2017	2,408	14,371	$969,364
2018	1,654	11,437	$727,282
2019	1,580	11,383	$752,382
2020	1,302	8,118	$557,209
2021	1,063	6,766	$399,865
2022	980	11,179	$646,963
2023	925	10,049	$550,648
2024	789	8,309	$413,714

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	600	4,076	$283,404
2016	859	5,924	$405,329
2017	1,018	6,672	$605,144
2018	1,110	7,058	$852,201
2019	1,119	7,243	$1,043,131
2020	1,090	7,861	$1,205,687
2021	1,061	7,857	$1,348,799
2022	1,177	9,097	$1,597,586
2023	1,201	9,412	$1,921,586
2024	1,239	9,889	$2,002,191

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$26,845
2016	23	79	$157,566
2017	11	29	$53,947
2018	N/R	39	$70,975
2019	N/R	87	$36,453
2020	N/R	90	$5,181
2021	N/R	N/R	N/R
2022	N/R	11	$25,054
2023	N/R	26	$59,076
2024	N/R	22	$50,510

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	594	962	$81
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	503	545	$72
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	320	2,411	$45
99439	Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month	160	326	$34
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	613	1,004	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	720	38,931	$743,253
Entresto	Sacubitril/Valsartan	345	17,316	$375,591
Jardiance	Empagliflozin	260	11,587	$216,127
Multaq	Dronedarone Hcl	102	5,602	$143,591
Repatha Sureclick	Evolocumab	133	6,278	$120,167

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	22	$50,510

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$608	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sakina A. Kamal, M.D.?

Tedicare shows public-source Medicare data for Sakina A. Kamal, M.D. (NPI 1619961000), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sakina A. Kamal, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sakina A. Kamal, M.D.?

Sakina A. Kamal, M.D. is linked to CARDIOLOGY ASSOCIATES OF WEST ALABAMA, PC (billing NPI 1669573721) in the available physician profile data.

Does Sakina A. Kamal, M.D. have Open Payments data?

Sakina A. Kamal, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.